(Circulation. 1997;96:4343-4348.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Medicine, Divisions of Endocrinology and Metabolism (J.L.M., R.M., W.H.D.) and Cardiology (L.L.B.) and Department of Pharmacology (R.H.-D., L.L.B.), University of California, San Diego.
| Abstract |
|---|
|
|
|---|
B-crystallin protect against
ischemic injury.
Methods and Results Our aim was to examine whether the
overexpression of hsp27 and
B-crystallin in neonatal and adult rat
cardiomyocytes would protect against ischemic
injury. Recombinant adenovirus expressing hsp27 or
B-crystallin
under the control of the cytomegalovirus promoter was used to infect
cardiac myocytes at high efficiency as assessed by
immunostaining. Overexpression was confirmed by Western
blot analysis. Cardiomyocytes were subjected to simulated
ischemic stress, and survival was estimated through assessment
of lactate dehydrogenase and creatine phosphokinase release. The hsp27
overexpression decreased lactate dehydrogenase release by 45±7.5% in
adult cardiomyocytes but had no effect in the neonatal
cells. In contrast,
B-crystallin overexpression was associated with
a decrease in cytosolic enzyme release in both adult (29±6.6%) and
neonatal (32±5.4%) cardiomyocytes. Decreased
endogenous hsp25 with an antisense adenovirus produced a
29±9.9% increase in damage with simulated ischemia.
Overexpression of the inducible hsp70 in adult
cardiomyocytes was associated with a 34±4.6% decrease in
lactate dehydrogenase release and is in line with our previous results
in neonatal cardiomyocytes.
Conclusions The increased expression of hsp27 and
B-crystallin
through an adenovirus vector system protects against ischemic
injury in adult cardiomyocytes. Likewise, the
overexpression of
B-crystallin protects against ischemic
damage in neonatal cardiomyocytes. Decreasing the high
levels of endogenous hsp25 present in neonatal
cardiomyocytes renders them more susceptible to damage
caused by simulated ischemia.
Key Words: ischemia adenovirus myocytes proteins
| Introduction |
|---|
|
|
|---|
Two candidate proteins for mediating a protective effect are the
small heat shock proteins
B-crystallin and hsp27 (hsp25 in rodents).
hsp27 and
B-crystallin share considerable sequence and structural
similarity, associate in vivo, and are induced by oxidative
stress.9 10 11 12 Both small heat shock proteins function as
molecular chaperones in protein biosynthesis to facilitate protein
folding and translocation.13 Protective effects of the
small heat shock proteins have been described against several noxious
stresses like hyperthermia, hypertonic stress, and various cytotoxic
agents, including cytoskeletal disruptors, but their effect on
ischemia-mediated injury in cardiac myocytes has not been
explored. Examples of the protective effect against heat stress by
small heat shock proteins include the demonstration that the amount of
hsp27 expressed by transfection in rodent and Chinese hamster cell
lines directly correlates with survival from
hyperthermia14 15 16 and that ectopic expression of
B-crystallin renders NIH 3T3 cells and glioma cells
thermoresistant.17 18 19 Therefore, both hsp27 and
B-crystallin can mediate stress tolerance, helping cells to endure a
variety of stresses. Both small heat shock proteins are also associated
with cytoskeletal structures, and stabilization of these elements may
contribute to the increased stress tolerance. For example, hsp27 acts
as an inhibitor of actin filament turnover in smooth muscle
cells and seems to stabilize the actin filaments.20 21
Stable overexpression of hsp27 in Chinese hamster lung cells confers
resistance to F-actin fragmentation induced by
H2O2 and menadione.22
B-Crystallin stabilizes cytoskeletal structures in glioma
cells.19 In cardiomyocytes,
B-crystallin
also associates with the intermediate filaments, especially desmin, an
association that is strengthened under ischemic
conditions.23 24
It was our aim to determine whether increased expression of the small
heat shock proteins hsp27 and
B-crystallin in rat cardiac myocytes
exerts a protective effect against ischemic injury. Recombinant
adenovirus were used to overexpress the human hsp27 (huhsp27) and the
rat
B-crystallin in the sense and antisense orientation. This
approach provides for high levels of transgene expression in the great
majority of cardiac myocytes used in the experiments. We examined the
effects of overexpression of these proteins on the extent of
ischemic damage in both neonatal and adult rat
cardiomyocytes. We also used the antisense orientation of
the genes in the adenovirus as a means of specifically decreasing the
levels of the corresponding endogenous small heat shock
proteins. We demonstrated, to our knowledge for the first time, that
the overexpression of hsp27 and
B-crystallin protects against
ischemic damage in cardiomyocytes and, further,
that decreasing the level of the endogenous hsp25 renders
these cells more susceptible to ischemic injury. We also
documented that protection is seen with hsp70i overexpression in adult
cardiomyocytes exposed to simulated ischemia.
| Methods |
|---|
|
|
|---|
B-crystallin, each in the sense and antisense
orientations. In addition, an insertless adenovirus was constructed to
be used as a control for effects of adenovirus infection. The 0.76-kb
coding region of the human hsp27 cDNA (provided by Drs L. Weber and E.
Hickey, University of Nevada [Reno])25 and the 0.76-kb
rat
B-crystallin cDNA (from Drs J. Goldman and A. Iwaki, College of
Physicians and Surgeons of Columbia University, New York,
NY)26 were used to make the constructs. The appropriate
fragments were cloned between the enhancer/promoter of the
cytomegalovirus immediate-early genes and the Simian virus 40
polyadenylation signal of the pACCMV. pLpA shuttle vector provided by
Dr R. Gerard. Replication-deficient adenovirus was generated through
homologous recombination of two plasmids (pJM17, a bacterial plasmid
that contains the full-length adenoviral genome, and the shuttle
vector) after cotransfection into E1 transformed human embryonic kidney
293 cells to produce E1-deleted adenovirus encoding the appropriate
transgene.27 The inducible rat hsp70 adenovirus was
constructed in a similar manner as we previously
described.2 Viral stocks were generated by infecting
confluent 293 cells, harvesting the cells, and concentrating the cells
through CsCl ultracentrifugation. Viral stocks were
then desalted through a Sepharose CL4B (Sigma Chemical Co) column into
a Tris-buffered solution, plaque-titered, aliquoted, and stored at
-70°C with 10% glycerol until use.
Isolation of Ventricular Cardiomyocytes
Neonatal cardiomyocytes were isolated through
collagenase/pancreatin digestion and Percoll gradient
separation from 1- to 2-day-old rats as previously
described.28 They were infected 1 day after isolation
at a multiplicity of infection (MOI) of 10:1 in 2%
heat-inactivated bovine serum containing DME. After 1 hour,
the medium was changed to no-serum DME. On day 2 after infection, the
cells were submitted to simulated ischemia, harvested for
Western blot analysis, or immunostained.
Adult cardiomyocytes are isolated from 250- to 300-g Sprague-Dawley rats through collagenase perfusion as previously described.29 They were infected 1 hour after plating onto laminin-coated dishes at an MOI of 10:1 in M199 supplemented with HEPES (7.7 mmol/L), taurine (5 mmol/L), creatinine (5 mmol/L), carnitine (2 mmol/L) and 1% BSA. The virus was washed away with a single media change. Then, 2 days later, they were processed in the same manner as the neonatal cells.
Simulated Ischemia
Simulated ischemia was achieved by placing cells in
hypotonic, balanced salt solution consisting of 1.3 mmol/L
CaCl2, 5 mmol/L KCl, 0.3 mmol/L
KH2PO4, 0.5 mmol/L MgCl2,
0.4 mmol/L MgSO4, 69 mmol/L NaCl, 4 mmol/L
NaHCO3, and 0.3 mmol/L Na2HPO4
without glucose or serum and made hypoxic for 6 hours (adult cells) or
12 hours (neonatal cells) at 37°C.1 Hypoxia was
attained with an airtight jar from which the oxygen was flushed with
argon for 5 minutes to achieve <0.2% oxygen.1 To
maintain hypoxia, the oxygen-consuming GasPak System from BBL
Microbiology Systems was used.1 At the end of the
experiment, the dishes were removed from the chamber with the medium,
and cells were separately assayed for both enzyme and protein
content.
Enzyme Quantitation
The cells were scraped into 2 mL of cold PBS and sonicated
(Ultrasonic Homogenizer 4710; Cole-Parmer) for 30
seconds followed by a 10-minute centrifugation at
150g to remove cell debris. This supernatant is taken to
represent total enzymatic activity remaining in the cells. The
enzymes in the media and from the sonicated cells were quantified
according to the Oliver and Rosalki method with the creatine
phosphokinase (CK) determination kit (Sigma Diagnostics),
and the Wroblewski and LaDue method was used in the lactate
dehydrogenase (LDH) determination kit (Sigma Diagnostics)
for LDH release. The amount of enzyme released in the nonstressed
controls is subtracted as background from the value obtained from the
ischemic cells. This value is then normalized to the amount
released by cells infected with the control adenovirus (which contains
no transgene). This is necessary to pool multiple primary
cardiomyocyte experiments. While treated in precisely the
same manner, there still may be significant variability in the extent
of enzyme release between experiments (ie, 20% to 40% of the total
amount of enzyme is released after 12 hours of simulated
ischemia).
Immunostaining and Protein Analysis
Cell extracts were prepared by washing plates twice with
ice-cold PBS and scraped into solution B containing 1% Triton x-100,
0.5% deoxycholate, and 5 µmol/L 2-mercaptoethanol, followed by
vigorous vortexing and cooling on ice for 15 minutes, before 15 minutes
of centrifugation at
12 000g.32 Protein concentration was
determined according to the Bradford assay (BRL). Protein samples were
fractionated on a 12% SDSpolyacrylamide gel and
electrotransferred onto nitrocellulose using a semidry electrotransfer
apparatus (BRL). The nitrocellulose membranes were reacted
with polyclonal anti-rodent hsp25, monoclonal anti-human hsp27 (both
from StressGen), or polyclonal anti-rodent
B-crystallin (kindly
provided by Drs K. Kegel, M. Head, and J. Goldman, Columbia University,
New York, NY) at a 1:1000 dilution. Protein loading was normalized by
using monoclonal antibodies to constitutive hsp70 (StressGen) and
sarcomeric
-actin (Sigma). Protein antibody complexes were
visualized either with the Vectastain Elite kit (Vector) using
diaminobenzidine plus nickel as a substrate or by using the Enhanced
Chemiluminescence kit (Amersham). Immunoblots were scanned
with a Scanjet 4C (Hewlett-Packard) and then digitized and
analyzed with the NIH Image analysis program.
For immunostaining, cells were washed with PBS and fixed with cold methanol for 5 minutes. Cell dishes were hydrated with TBS containing 0.1% BSA (fraction V; Sigma), and the primary antibody was added at 1:100. The samples were then processed using the Vectastain ABC kit (Vector).
Statistical Analysis
Results are expressed as mean±SEM. Statistical significance was
assessed with one-way ANOVA. Tukey-Kramer post-test comparisons were
performed when appropriate.
| Results |
|---|
|
|
|---|
|
Known amounts of recombinant human hsp27 proteins were run on
denaturing polyacrylamide gels in parallel with extracts from
control and huhsp27 adenovirusinfected cell and then
electrotransferred. The level of transgene expression (Fig 2A
, lanes 3 and 4 versus lane 5) was
100 ng/20 µg total protein (0.5%). Extracts from noninfected
cells demonstrated the specificity of the antibody (Fig 2A
, lane 2).
Similar results were seen with the adult cardiomyocytes
(data not shown). We also examined the effectiveness of the antisense
huhsp27 infection by Western blot analysis. In neonatal
cardiomyocytes, antisense infection reduces the
endogenous hsp25 by 80% when normalized for loading with
the heat shock cognate 70 protein (Fig 2B
, lane 3 versus lane 1). In
the adult cardiomyocytes, we were not able to detect a
significant reduction using the antisense to huhsp27 (data not shown),
probably due to a slower hsp25 protein turnover. The adenovirus
encoding
B-crystallin leads to effective transgene expression as
demonstrated by Western blots (Fig 3A
, lane 2 versus lane 1; Fig 3B
, lane 1 versus lane 3). Adult cardiac
myocytes express a higher level of endogenous
B-crystallin than do neonatal myocytes (compare Fig 3A
with 3B).
These findings are in line with the in vivo results showing that
B-crystallin levels are higher in adult rat hearts than in neonatal
rat hearts.31 32 The level of endogenous
B-crystallin does not seem to be significantly altered with the use
of the antisense
B-crystallin adenovirus in neonatal
cardiomyocytes (Fig 3A
, lane 4) or in adult myocytes (data
not shown). This could be due to the slow turnover of
B-crystallin
protein. A very low
B-crystallin turnover has been seen in the lens
of the eye.
|
|
After the effectiveness of infection and the time at which the small
heat shock protein transgenes are maximally expressed were established,
we submitted the cells to simulated ischemia or maintained them
under normal conditions to assess the potential protective effects of
hsp27 and
B-crystallin. The results of experiments using adult and
neonatal cardiac myocytes with altered levels of
B-crystallin are
shown in Fig 4
. In neonatal and adult
cardiac myocytes, a substantial decrease of ischemic injury was
achieved by overexpression of
B-crystallin. For example, the release
of CK was decreased by 32±5.4% in neonatal cardiac myocytes; in adult
cardiac myocytes, LDH release was decreased by 29±6.6% in
B-crystallinoverexpressing cells. Infection of cells with control
virus did not lead to significantly altered CK release. Expression of
the
B-crystallin antisense construct in neonatal or adult cardiac
myocytes did not influence enzyme release. These results are in accord
with the unchanged
B-crystallin protein levels as shown in Fig 3
.
|
The results of experiments using adult and neonatal cardiac myocytes
and altering the levels of hsp27 and hsp70i expression are shown in Fig 5
. As determined by Western blot
analysis, hsp25 levels are much lower in adult cardiac myocytes
than in neonatal cardiac myocytes. In line with these results, we found
that increasing hsp27 levels in adult cardiac myocytes resulted in
decreased injury by simulated ischemia, as indicated by a
45±7.5% decrease in LDH release. In contrast, in neonatal cardiac
myocytes, expression of the hsp27 transgene did not lead to decreased
CK release. Expression of the antisense message to hsp27 leads to a
significant decline of endogenous hsp25 protein and
increased CK release. In contrast, in adult cardiac myocytes, the
antisense hsp27 vector did not lower hsp27 protein levels as described
above, and in line with these results, no increase in LDH release
occurred. We also examined the effect of overexpression of hsp70i in
adult cardiomyocytes. With this construct, we saw a
34±4.6% decrease in LDH release after ischemic injury, which
is in accord with our previously published neonatal
cardiomyocyte results (33±3%).2
|
We also examined the protective effect of
B-crystallin expression
against ischemic injury of various lengths in neonatal
cardiomyocytes. The same degree of protection was observed
at 4 hours (30±7.5% decrease in CK release) and 8 hours (36±9.2%),
as shown in Fig 4
(32±5.4%) for 12 hours of simulated
ischemia. It should be mentioned that there was no significant
difference in enzyme release between cells infected with the control
virus and noninfected cells and that all results are normalized to
enzyme release by cells infected with the control insertless virus.
| Discussion |
|---|
|
|
|---|
B-crystallin in adult cardiac myocytes
provides for diminished injury from simulated ischemia. The
ability of increased levels of
B-crystallin to mediate increased
protection against ischemic injury in neonatal and adult
cardiac myocytes is of special interest.
B-Crystallin was initially
identified as a protein present in high concentrations in the lens
of the eye, and its presence in the heart has only recently received
attention. The precise mechanism by which the increased level of
B-crystallin exerts a protective effect against ischemic
injury is currently unclear, but protection may result from
stabilization of specific cellular structures.
B-Crystallin is
associated with the desmin-based intermediate filaments, which play a
role in anchoring I bands of the myofibril to the intercalated
disc,23 a region that seems to be an important target for
ischemic damage in cardiac myocytes.33 In contrast
to the increased protection resulting from an enhanced
B-crystallin
expression mediated by infection with adenoviral vectors expressing the
transgene in the sense orientation, placement of the
B-crystallin
gene in the antisense orientation did not alter ischemic
injury. Assessment of the amount of
B-crystallin in cells infected
with adenovirus expressing the antisense transgene showed that no
significant decrease occurred in
B-crystallin protein levels. This
is most likely due to the stability of the
B-crystallin
protein.34
The protective effect provided by increased expression of hsp27 was
limited to adult cardiac myocytes and therefore not as broadly based as
that observed with
B-crystallin. In neonatal cardiac myocytes,
adenovirus-mediated hsp27 transgene expression did not result in a
protective effect against ischemic injury; this is most likely
due to the already high control level of hsp25 protein in neonatal
cardiac myocytes, levels that markedly exceed that found in adult
cardiac myocytes (unpublished data, 1996). In line with the lower level
of hsp25 in adult cardiac myocytes (10% to 20% as much as in neonatal
cardiomyocytes), increasing hsp27 levels through
adenovirus-based transgene expression in adult cardiac myocytes
resulted in increased protection against ischemic injury. A
hsp27 dose-dependent protection also has been reported for cells
exposed to a lethal heat shock.16 The precise mechanism by
which hsp27 mediates this protective effect is currently unclear, but
it has also been demonstrated that hsp27 associates with actin
microfilaments and influences microfilament organization. Both
B-crystallin and hsp27 therefore associate with the cytoskeleton and
serve important functions in the maintenance of this important
cellular structure. It is also possible the
phosphorylation status of hsp27 markedly influences its
function.21 22
The importance of high hsp25 levels in neonatal cardiac myocyte for
normal cell function and integrity is further emphasized by the results
from hsp27 antisense expression in neonatal cardiac myocytes. Infection
of neonatal cardiac myocytes with adenoviral vectors expressing
antisense hsp27 results in a marked lowering of hsp25 levels, which
leads to enhanced ischemic injury. In contrast to
B-crystallin, the half-life of the hsp27 protein is shorter; within
2 days of hsp27 antisense expression, hsp25 protein levels are
significantly lower in neonatal cardiac myocytes. In adult cardiac
myocytes, hsp27 antisense expression did not lower hsp25 protein levels
and ischemic injury was unchanged, again emphasizing the close
correlation between hsp25/27 protein levels and the extent of
ischemic injury. The consistent protective effect of
overexpressing hsp70i was also demonstrated in adult
cardiomyocytes.
In summary, our results show that increased expression of the small
heat shock proteins
B-crystallin and hsp27 in adult cardiac myocytes
through an adenovirus vectorbased approach leads to increased
protection against injury mediated by simulated ischemia. It is
therefore of interest to explore in future studies whether specific
targets for this protective effect can be identified.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received June 11, 1997; revision received August 27, 1997; accepted September 15, 1997.
| References |
|---|
|
|
|---|
-crystallin and mouse small heat
shock protein. J Biol Chem.. 1993;268:1046-1052.
B crystallin can form a
complex, which dissociates by heat shock. J Biol
Chem.. 1992;267:12936-12941.
B-Crystallin is a small heat shock protein.
Proc Natl Acad Sci U S A.. 1991;88:3652-3656.
B crystallin and HSP27 in response to
physiological stress. J Cell
Physiol.. 1994;159:41-50.[Medline]
[Order article via Infotrieve]
B
Crystallin expression in mouse NIH 3T3 fibroblasts: glucocorticoid
responsiveness and involvement in thermal protection. Mol
Cell Biol.. 1993;13:1824-1835.
B crystallin expression and
B crystallin expressing L929
transfectants. Mol Cell Biochem.. 1996;55:51-60.
B-Crystallin in cardiac tissue: association with actin and
desmin filaments. Circ Res.. 1992;71:288-294.
-crystallin B chain alternative transcriptional
initiation. J Biol Chem.. 1990;265:22197-22203.
B-crystallin in the rat determined with a sensitive
immunoassay system. Biochim Biophys Acta.. 1991;1074:201-208.[Medline]
[Order article via Infotrieve]
B-crystallin in
cardiac and skeletal muscle during mouse development. Dev
Dyn.. 1997;208:75-84.[Medline]
[Order article via Infotrieve]
and B crystallins: unique thermal
stability of
crystallin. FEBS Lett.. 1988;236:109-114.[Medline]
[Order article via Infotrieve]This article has been cited by other articles:
![]() |
A. Havasi, Z. Li, Z. Wang, J. L. Martin, V. Botla, K. Ruchalski, J. H. Schwartz, and S. C. Borkan Hsp27 Inhibits Bax Activation and Apoptosis via a Phosphatidylinositol 3-Kinase-dependent Mechanism J. Biol. Chem., May 2, 2008; 283(18): 12305 - 12313. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Lu, L. Chen, X.-L. Cai, and H.-T. Yang Overexpression of heat shock protein 27 protects against ischaemia/reperfusion-induced cardiac dysfunction via stabilization of troponin I and T Cardiovasc Res, April 25, 2008; (2008) cvn091v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kardys, N. Rifai, O. Meilhac, J.-B. Michel, J. L. Martin-Ventura, J. E. Buring, P. Libby, and P. M Ridker Plasma Concentration of Heat Shock Protein 27 and Risk of Cardiovascular Disease: A Prospective, Nested Case-Control Study Clin. Chem., January 1, 2008; 54(1): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, I. S. Ali, and R. W. Currie Insulin-induced myocardial protection in isolated ischemic rat hearts requires p38 MAPK phosphorylation of Hsp27 Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H74 - H87. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Legare, A. Oxner, O. Heimrath, T. Myers, and R. W. Currie Heat shock treatment results in increased recruitment of labeled PMN following myocardial infarction Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3210 - H3215. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Turakhia, C. D. Venkatakrishnan, K. Dunsmore, H. Wong, P. Kuppusamy, J. L. Zweier, and G. Ilangovan Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27 Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3111 - H3121. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Blunt, A. T. Creek, D. C. Henderson, and P. A. Hofmann H2O2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1518 - H1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-T. Hsu, Y.-C. Hsieh, W. H. Kan, J. G. Chen, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry Role of p38 mitogen-activated protein kinase pathway in estrogen-mediated cardioprotection following trauma-hemorrhage Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2982 - H2987. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rafiee, M. E. Theriot, V. M. Nelson, J. Heidemann, Y. Kanaa, S. A. Horowitz, A. Rogaczewski, C. P. Johnson, I. Ali, R. Shaker, et al. Human esophageal microvascular endothelial cells respond to acidic pH stress by PI3K/AKT and p38 MAPK-regulated induction of Hsp70 and Hsp27 Am J Physiol Cell Physiol, November 1, 2006; 291(5): C931 - C945. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wei, W. Campbell, and R. S. Vander Heide Heat shock-induced cardioprotection activates cytoskeletal-based cell survival pathways Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H638 - H647. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zolk, C. Schenke, and A. Sarikas The ubiquitin-proteasome system: Focus on the heart Cardiovasc Res, June 1, 2006; 70(3): 410 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-h. Xi, F. Bai, R. McGaha, and U. P. Andley Alpha-crystallin expression affects microtubule assembly and prevents their aggregation FASEB J, May 1, 2006; 20(7): 846 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cao, N. Dronadula, F. Rizvi, Q. Li, K. Srivastava, W. T. Gerthoffer, and G. N. Rao Novel Role for STAT-5B in the Regulation of Hsp27-FGF-2 Axis Facilitating Thrombin-Induced Vascular Smooth Muscle Cell Growth and Motility Circ. Res., April 14, 2006; 98(7): 913 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. De Celle, F. Vanrobaeys, P. Lijnen, W. M. Blankesteijn, S. Heeneman, J. Van Beeumen, B. Devreese, J. F. M Smits, and B. J. A Janssen Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion Exp Physiol, July 1, 2005; 90(4): 593 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhang, Z. Xu, X.-R. He, L. H. Michael, and C. Patterson CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2836 - H2842. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Casey, P. G. Arthur, and M. A. Bogoyevitch Proteomic Analysis Reveals Different Protein Changes during Endothelin-1- or Leukemic Inhibitory Factor-induced Hypertrophy of Cardiomyocytes in Vitro Mol. Cell. Proteomics, May 1, 2005; 4(5): 651 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-C. Fan, X. Ren, J. Qian, Q. Yuan, P. Nicolaou, Y. Wang, W. K. Jones, G. Chu, and E. G. Kranias Novel Cardioprotective Role of a Small Heat-Shock Protein, Hsp20, Against Ischemia/Reperfusion Injury Circulation, April 12, 2005; 111(14): 1792 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hollander, J. L. Martin, D. D. Belke, B. T. Scott, E. Swanson, V. Krishnamoorthy, and W. H. Dillmann Overexpression of Wild-Type Heat Shock Protein 27 and a Nonphosphorylatable Heat Shock Protein 27 Mutant Protects Against Ischemia/Reperfusion Injury in a Transgenic Mouse Model Circulation, December 7, 2004; 110(23): 3544 - 3552. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Inserte, D. Garcia-Dorado, M. Ruiz-Meana, L. Agullo, P. Pina, and J. Soler-Soler Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism Cardiovasc Res, October 1, 2004; 64(1): 105 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Depre, S.-J. Kim, A. S. John, Y. Huang, O. E. Rimoldi, J. R. Pepper, G. D. Dreyfus, V. Gaussin, D. J. Pennell, D. E. Vatner, et al. Program of Cell Survival Underlying Human and Experimental Hibernating Myocardium Circ. Res., August 20, 2004; 95(4): 433 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-C. Fan, G. Chu, B. Mitton, Q. Song, Q. Yuan, and E. G. Kranias Small Heat-Shock Protein Hsp20 Phosphorylation Inhibits {beta}-Agonist-Induced Cardiac Apoptosis Circ. Res., June 11, 2004; 94(11): 1474 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mao, Y. Wang, Z. Li, K. L. Ruchalski, X. Yu, J. H. Schwartz, and S. C. Borkan Hsp72 Interacts with Paxillin and Facilitates the Reassembly of Focal Adhesions during Recovery from ATP Depletion J. Biol. Chem., April 9, 2004; 279(15): 15472 - 15480. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bullard, C. Ferguson, A. Minajeva, M. C. Leake, M. Gautel, D. Labeit, L. Ding, S. Labeit, J. Horwitz, K. R. Leonard, et al. Association of the Chaperone {alpha}B-crystallin with Titin in Heart Muscle J. Biol. Chem., February 27, 2004; 279(9): 7917 - 7924. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun, J.-M. Fontaine, J. S. Rest, E. A. Shelden, M. J. Welsh, and R. Benndorf Interaction of Human HSP22 (HSPB8) with Other Small Heat Shock Proteins J. Biol. Chem., January 23, 2004; 279(4): 2394 - 2402. |